文献速递心境障碍

面对面与网络心理治疗抑郁症随机临床试验的预后风险因素:系统综述与元回归分析

Prognostic Risk Factors in Randomized Clinical Trials of Face-to-Face and Internet-Based Psychotherapy for Depression: A Systematic Review and Meta-Regression Analysis.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

面对面治疗试验的预后风险指数显著高于网络化治疗试验。预后风险指数与效应量无显著关联,但敏感性分析结果不一,提示网络化治疗证据的外推性需更多具临床代表性样本的试验。

要点

  • 面对面治疗试验样本的预后风险指数显著高于网络化治疗试验。
  • 预后风险指数与治疗效应量未见显著关联,但敏感性分析结果不一。
  • 网络化治疗证据的外推性受限于样本预后风险因素较低,需改进报告。

核心结论

  • 面对面治疗与网络化治疗的随机对照试验样本在预后风险因素上存在差异。
  • 这些差异对当前网络化治疗抑郁症证据的外推性具有影响。
  • 需要更多采用临床代表性样本的网络化干预随机对照试验,并改进预后风险因素的报告。

研究设计与样本

  • 系统综述与元回归分析,检索PsycINFO、Cochrane CENTRAL及已发表元分析的参考文献列表,时间范围为2000年1月1日至2021年12月31日。
  • 由2名独立观察者提取数据,使用Cochrane修订版偏倚风险工具评估偏倚风险,研究在OSF注册并遵循PRISMA报告指南。

主要发现

  • 面对面治疗试验48项(46%),网络化治疗试验57项(54%)。
  • 预后风险指数在面对面治疗试验中显著高于网络化治疗试验(面对面:均值[SD] 3.55[1.75],中位数[IQR] 3.5[2.0-4.5];网络化:均值[SD] 2.27[1.66],中位数[IQR] 2.0[1.0-3.5];z=-3.68,P<.001;Hedges g=0.75;95%CI 0.36-1.15)。
  • 随机效应元回归分析未发现预后风险指数与效应量之间存在关联。
  • 排除离群值及考虑偏倚风险或小样本效应的敏感性分析对预后风险指数与效应量的关联得出混合结果。

关键数值与推荐

  • 主要结局为治疗结束时抑郁症状的标准化均数差(Hedges g效应量),采用标准患者自评问卷评估,正值表示干预组较对照组改善更大。
  • 预后风险指数为12个预设个体指标之和,评分范围0至12,分数越高表示样本包含预后更差的患者。
  • 元回归分析针对对照组类型进行了调整。

临床怎么用

  • 解读网络化心理治疗抑郁症的证据时,需考虑其试验样本预后风险因素较低可能限制外推性。
  • 在临床决策中,应关注面对面与网络化治疗试验样本在预后风险因素上的差异。
  • 未来试验应报告预后风险因素并纳入更具临床代表性的样本。

局限性

  • 敏感性分析(排除离群值、考虑偏倚风险或小样本效应)对预后风险指数与效应量的关联得出混合结果。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Variables such as severe symptoms, comorbidity, and sociodemographic characteristics (eg, low educational attainment or unemployment) are associated with a poorer prognosis in adults treated for depressive symptoms. The exclusion of patients with a poor prognosis from RCTs is negatively associated with the generalizability of research findings. OBJECTIVE: To compare the prognostic risk factors (PRFs) in patient samples of RCTs of face-to-face therapy (FTF) and internet-based therapy (IBT) for depression. DATA SOURCES: PsycINFO, Cochrane CENTRAL, and reference lists of published meta-analyses were searched from January 1, 2000, to December 31, 2021. STUDY SELECTION: RCTs that compared FTF (individual or group therapy) and IBT (guided or self-guided interventions) against a control (waitlist or treatment as usual) in adults with symptoms of depression were included. DATA EXTRACTION AND SYNTHESIS: Data were extracted by 2 independent observers. The Cochrane revised risk-of-bias tool was used to assess the risk of bias. The study was preregistered with OSF Registries and followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. MAIN OUTCOMES AND MEASURES: The primary outcome was the standardized mean difference (Hedges g effect size) in depressive symptoms at treatment termination (assessed with standard patient self-report questionnaires), with a positive standardized mean difference indicating larger improvements in the intervention compared with those in the control group. Meta-regression analyses were adjusted for the type of control group. Three preregistered and 2 exploratory sensitivity analyses were conducted. A prognostic risk index (PROG) was created that calculated the sum of 12 predefined individual indicators, with scores ranging from 0 to 12 and higher scores indicating that a sample comprised patients with poorer prognoses. RESULTS: This systematic review and meta-regression analysis identified 105 eligible RCTs that comprised 18 363 patients. In total, 48 studies (46%) examined FTF, and 57 studies (54%) examined IBT. The PROG was significantly higher in the RCTs of FTF than in the RCTs of IBT (FTF: mean [SD], 3.55 [1.75]; median [IQR], 3.5 [2.0-4.5]; IBT: mean [SD], 2.27 [1.66]; median [IQR], 2.0 [1.0-3.5]; z = -3.68, P < .001; Hedges g = 0.75; 95% CI, 0.36-1.15). A random-effects meta-regression analysis found no association of the PROG with the effect size. Sensitivity analyses with outliers excluded and accounting for risk of bias or small-study effects yielded mixed results on the association between the PROG and effect size. CONCLUSIONS AND RELEVANCE: The findings of this systematic review and meta-regression analysis suggest that samples of RCTs of FTF vs IBT differ with regard to PRFs. These findings have implications for the generalizability of the current evidence on IBT for depression. More RCTs of internet-based interventions with clinically representative samples are needed, and the reporting of PRFs must be improved.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Merzhvynska M, Wolf M, Krieger T, et al. Prognostic Risk Factors in Randomized Clinical Trials of Face-to-Face and Internet-Based Psychotherapy for Depression: A Systematic Review and Meta-Regression Analysis. JAMA Psychiatry. 2024. PMID: 37819635. doi:10.1001/jamapsychiatry.2023.3861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。